Do you really want to gamble your barrier on a miracle claim
Specifically, robust and consistent protective effects were observed for schizophrenia and anxiety disorders, as evidenced by significant associations across all datasets analyzed
Inhibition of GCS It is well known [27, 41] that GSH is a competitive inhibitor against glutamate of GCS, the enzyme that catalyzes the synthesis of glutamyl-cysteine
Weight loss Available in NZ = Liraglutide high dose (Saxenda, daily injection) Self-funding needed ($500-600/month) Not available in NZ = Semaglutide (Ozempic, Wegovy) or Tirzepatide (Mounjaro), as of May 2023 Side effects, particularly upper gastrointestinal, are common with GLP-1 agonist initiation
You were recommended to me, and now I see why
Cheng Y, Cheng C, Yao J, Yu Y, Liu Y, Zhang H, et al